Healthremedy123.com – A clinical diagnosis of scleromalacia perforans is difficult to make because many underlying connective tissue disorders or autoimmune diseases are often associated with the disorder. Physicians should rule out any autoimmune disorders before determining a correct diagnosis of scleromalacia. To confirm a diagnosis, laboratory tests such as a complete blood count with differential, erythrocye sedimentation rate, C-reactive protein, serum uric acid, syphilis serology, and triglyceride levels are required. Surgical procedures are needed to repair severe thinning of the eyeball and the loss of vision in the affected eye.
Diagnosis of Perforated Scleromalacia by an Ophthalmologist
Diagnosis of scleromalacia perforans is usually made with a thorough physical exam by an ophthalmologist. The doctor will use a high-intensity light beam to view the inside of the eye. During this procedure, the physician will look for signs of scleromalacia per forans, which are often accompanied by a decreased blood vessel size in the back of the eye. If no other cause is found, the diagnosis of scleromalacia can be made with clinical symptoms.
The first report of scleromalacia perforans was made in 1930 by van der Hoeve. The disease is characterized by bilateral thinning and epithelioid tissue. The cause is not fully understood but is suspected to be autoimmune in nature. It is usually idiopathic, although there are many associated systemic conditions. Scleromalacia perforans is not a sign of any underlying disease.
A doctor can diagnose scleromalacia perforans by using clinical symptoms. In rare cases, a patient may exhibit no symptoms at all or may have a different cause. If blood tests reveal elevated C-reactive protein levels, the diagnosis is usually based on other autoimmune conditions. In some cases, an autoantibody screen can detect an undiagnosed autoimmune disorder. However, a blood test can’t reliably diagnose scleromalacia peroforans.
The Most Common Symptoms of Scleromalacia Perforans
The most common symptom of scleromalacia perforans is an enlarged eye. Patients with this condition may have symptoms related to eye dryness. Sodium versenate eye drops can help with eye irritation, as can topical cyclosporin A. Treatment can also be done with a scleral graft, which can be patched over the ruptured sclera.
Currently, no blood test can accurately diagnose scleromalacia perforans. Patients with this disease can show yellow or gray patches in the sclera. They may also complain of eye redness. If left untreated, scleromalacia can progress to cataracts. Long-term use of corticosteroids may also cause glaucoma. Thankfully, scleromalacia perforan can be treated without surgery.
Symptoms of scleromalacia perforans are generally asymptomatic. Most patients with this condition will experience yellow or gray patches on the sclera. Symptoms of scleromalatoid arthritis include visual impairment and aphasia. A slit lamp examination can detect scleromalacia perforana if it is present in the eye.
Scleromalacia Perforans is a Chronic Autoimmune Disorder
Symptomatic scleromalacia perforans is not a life-threatening disease and can be easily detected with a slit lamp. A slit lamp can also detect scleromalacia perforana if the patient is asymptomatic. Scleromalacia perforans is a chronic autoimmune disorder, but can also cause vision impairment if left untreated.
The symptoms of scleromalacia perforans are similar to those of rheumatoid arthritis, but the latter is the more severe condition. The disease is a complication of autoimmune processes such as gout and ankylosing spondylitis. Its symptoms usually include pain, inflammation, and asymmetry of the eyes. Scleromalacia perforans is often a sign of a more serious disease, and doctors should consult with a specialized ophthalmologist for diagnosis.
The primary treatment for scleromalacia perforans is a combination of systemic and aggressive approaches. DMARDs are typically necessary for treatment. In some cases, a biologic DMARD, called adalimumab, has been used to treat scleromalacia perforana. This treatment has had promising results in patients with this type of disease.
